ESR and CRP were both observed to be associated with advanced stages and worse ECOG status in our study, verifying the ability of these inflammatory parameters as biomarkers to indicate cancer severity; this may, thus, help clinicians make clinical decisions. The gene discussed is CRP; the disease is cancer.